The committee voted unanimously (18 to 0) that the efficacy findings from studies of bedaquiline support the proposed indication for the treatment of multidrug-resistant tuberculosis (MDR-TB) as part of combination therapy in adults. The committee also agreed that the safety findings supported the proposed indication, by a vote of 11 to 7.
Aids activist organisation Treatment Action Group (TAG), along with the Global TB Community Advisory Board (TB CAB), HIV i-Base, South Africa’s Treatment Action Campaign (TAC), Médecins sans Frontières (MSF) and the Southern African HIV Clinicians’...